NAMD

Clinical trials for NAMD explained in plain language.

Never miss a new study

Get alerted when new NAMD trials appear

Sign up with your email to follow new studies for NAMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2

Longer-Lasting eye injection could cut treatment visits for macular disease

Disease control Not yet recruiting

This study looks at whether switching to a higher-dose eye injection called aflibercept 8 mg can allow people with neovascular age-related macular degeneration (nAMD) or diabetic macular oedema (DME) to go longer between treatments. It follows adults in Portugal who have already …

Matched conditions: NAMD

Sponsor: Grupo de Estudos da Retina • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC

NAMD

Get alerted when new NAMD trials appear

Longer-Lasting eye injection could cut treatment visits for macular disease